Literature DB >> 33040495

Cardiovascular prognosis: a new role for ceramides and other cardiometabolites.

Jasmine M F Wu1, P Christian Schulze1.   

Abstract

Entities:  

Year:  2020        PMID： 33040495      PMCID： PMC7754998          DOI： 10.1002/ehf2.13025

Source DB:  PubMed          Journal:  ESC Heart Fail        ISSN： 2055-5822


× No keyword cloud information.
  28 in total

1.  Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study.

Authors:  Ruth Dubin; Yongmei Li; Joachim H Ix; Michael G Shlipak; Mary Whooley; Carmen A Peralta
Journal:  Am Heart J       Date:  2012-02       Impact factor: 4.749

Review 2.  Absorption and lipoprotein transport of sphingomyelin.

Authors:  Ake Nilsson; Rui-Dong Duan
Journal:  J Lipid Res       Date:  2005-10-26       Impact factor: 5.922

3.  Ceramide is upregulated and associated with mortality in patients with chronic heart failure.

Authors:  Jingjia Yu; Wei Pan; Ruizheng Shi; Tianlun Yang; Yuanjian Li; Guolong Yu; Yongping Bai; Edward H Schuchman; Xingxuan He; Guogang Zhang
Journal:  Can J Cardiol       Date:  2014-12-11       Impact factor: 5.223

4.  Increased de novo ceramide synthesis and accumulation in failing myocardium.

Authors:  Ruiping Ji; Hirokazu Akashi; Konstantinos Drosatos; Xianghai Liao; Hongfeng Jiang; Peter J Kennel; Danielle L Brunjes; Estibaliz Castillero; Xiaokan Zhang; Lily Y Deng; Shunichi Homma; Isaac J George; Hiroo Takayama; Yoshifumi Naka; Ira J Goldberg; P Christian Schulze
Journal:  JCI Insight       Date:  2017-07-20

5.  A critical role for ceramide synthase 2 in liver homeostasis: I. alterations in lipid metabolic pathways.

Authors:  Yael Pewzner-Jung; Hyejung Park; Elad L Laviad; Liana C Silva; Sujoy Lahiri; Johnny Stiban; Racheli Erez-Roman; Britta Brügger; Timo Sachsenheimer; Felix Wieland; Manuel Prieto; Alfred H Merrill; Anthony H Futerman
Journal:  J Biol Chem       Date:  2010-01-28       Impact factor: 5.157

6.  New insights on the use of desipramine as an inhibitor for acid ceramidase.

Authors:  Saeed Elojeimy; David H Holman; Xiang Liu; Ahmed El-Zawahry; Maristella Villani; Joseph C Cheng; Ayman Mahdy; Youssef Zeidan; Alicja Bielwaska; Yusuf A Hannun; James S Norris
Journal:  FEBS Lett       Date:  2006-08-04       Impact factor: 4.124

7.  Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials.

Authors:  Roberto Latini; Lars Gullestad; Serge Masson; Ståle Haugset Nymo; Thor Ueland; Ivan Cuccovillo; Mari Vårdal; Barbara Bottazzi; Alberto Mantovani; Donata Lucci; Nobuhito Masuda; Yukio Sudo; John Wikstrand; Gianni Tognoni; Pål Aukrust; Luigi Tavazzi
Journal:  Eur J Heart Fail       Date:  2012-06-27       Impact factor: 15.534

Review 8.  Serine palmitoyltransferase, a key enzyme of sphingolipid metabolism.

Authors:  Kentaro Hanada
Journal:  Biochim Biophys Acta       Date:  2003-06-10

9.  Ceramide is a cardiotoxin in lipotoxic cardiomyopathy.

Authors:  Tae-Sik Park; Yunying Hu; Hye-Lim Noh; Konstantinos Drosatos; Kazue Okajima; Jonathan Buchanan; Joseph Tuinei; Shunichi Homma; Xian-Cheng Jiang; E Dale Abel; Ira J Goldberg
Journal:  J Lipid Res       Date:  2008-05-30       Impact factor: 5.922

10.  Increased circulating IgG levels, myocardial immune cells and IgG deposits support a role for an immune response in pre- and end-stage heart failure.

Authors:  Patricia van den Hoogen; Saskia C A de Jager; Manon M H Huibers; Arjan H Schoneveld; Yustina M Puspitasari; Gideon B Valstar; Marish I F J Oerlemans; Roel A de Weger; Pieter A Doevendans; Hester M den Ruijter; Jon D Laman; Aryan Vink; Joost P G Sluijter
Journal:  J Cell Mol Med       Date:  2019-09-26       Impact factor: 5.310
View more
  1 in total

1.  Cardiovascular prognosis: a new role for ceramides and other cardiometabolites.

Authors:  Jasmine M F Wu; P Christian Schulze
Journal:  ESC Heart Fail       Date:  2020-10-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.